1. Bundesministerium. Bundesministerium für Gesundheit - Früherkennung und Vorsorge. [Online] 2014. [Zitat vom: 21. Juli 2014.]
http://www.bmg.bund.de/fileadmin/dateien/Downloads/F/Frueherkennung_und_Vorsorg eleistungen_der_GKV/Krebs_Vorsorge-_und_Frueherkennungsleistungen.pdf.
2. Robert-Koch-Institut. Beiträge zur Gesundheitsberichterstattung des Bundes- Krebs in Deutschland 2009/2010, 9. Ausgabe. [Online] 2013. [Zitat vom: 21. Juli 2014.]
http://www.rki.de/Krebs/DE/Content/Publikationen/Krebs_in_Deutschland/kid_2013/kreb s_in_deutschland_2013.pdf?__blob=publicationFile.
3. Senn HJ, Drings P, Glaus A, et al. Checkliste Onkologie 5. Auflage. Stuttgart : Georg Thieme Verlag, 2001.
4. G, Herold. Innere Medizin. Köln : Gerd Herold, 2013.
5. Becker H, Encke A, Röher HD. Viszeralchirurgie, 2. Auflage. München : Elsevier (Urban & Fischer Verlag), 2006.
6. onkodin-das kolorektale Karzinom. [Online] 2007. www.onkodin.de.
7. Possinger K, Regierer AC. Facharzt Hämatologie Onkologie. München : Elsevier, Urban und Fischer, 2007.
8. Arasteh. Duale Reihe, Innere Medizin, 2. AUflage. Stuttart : Thieme-Verlag, 2009.
9. Bruch HP, Trentz O. Berchtold- Chirurgie, 6. Auflage. München : Elsevier (Urban &
Fischer Verlag), 2008.
10. Böcker W, Denk H, Heitz PU, Moch H. Pathologie, 4. Auflage. München : Elsevier (Urban & Fischer Verlag), 2008.
11. Hirner A, Weise K. Chirurgie, 2. Auflage. Stuttgart : Thieme-Verlag, 2008.
12. Renz-Polster H, Krautzig S, Braun J. Basislehrbuch Innere Medizin, 3. Auflage.
München : Elsevier: Urban & Fischer-Verlag, 2006.
13. S3-Leitlinie Version 1.0. [Online] Juni 2013.
http://www.krebsgesellschaft.de/download/ll_krk_langfassung_ol.pdf.
14. Müller M. Chirurgie für Studium und Praxis: unter Berücksichtigung des
Gegenstandskataloges und der mündlichen Examina in den Ärztlichen Prüfungen ; 2010/2011. Breisach : Medizinische Verlags- und Informationsdienste, 2010.
15. Prinz C. Basiswissen Innere Medizin. Heidelberg : Springer- Verlag, 2012.
16. Karges W, Al Dahouk S. Innere Medizin in 5 Tagen. Heidelberg : Springer Medizin Verlag, 2009.
17. Morán A, Ortega P, de Juan C, et al. Differential colorectal carcinogenesis:
Molecular basis and clinical relevance. World journal of gastrointestinal oncology. 2010, Bde. 2-3, 151-8.
18. Alexander K, Daniel WG, Diener HC, et al. Thiemes Innere Medizin (TIM).
Stuttgart : Georg Thieme Verlag, 1999.
19. Baretton GB. Der serratierte Karzinogeneseweg im Kolorektum. Der Pathologe. 31, 2010, 9-15.
20. Oono Y, Fu K, Nakamura H, et al. Progression of a sessile serrated adenoma to an early invasive cancer within 8 months. Digestive Diseases and Sciences. 2009, Bde.
54-4, 906-909.
21. Pox C, Schmiegel W, Nitschmann S. ASS zur Prophylaxe kolorektaler Karzinome.
Der Internist. 2008, Bd. 49, 360-362.
22. Wolin KY, Yan Y, Colditz GA, et al. Physical activity and colon cancer prevention:
a meta-analysis. British journal of cancer. 2009, Bde. 100-4, 611-6.
23. Colbert LH, Hartman TJ, Malila N, et al. Physical activity in relation to cancer of the colon and rectum in a cohort of male smokers. Cancer epidemiology, biomarkers &
prevention. 2001, Bde. 10-3, 265-8.
24. Howard RA, Freedman DM, Park Y, et al. Physical activity, sedentary behavior, and the risk of colon and rectal cancer in the NIH-AARP Diet and Health Study. Cancer causes & control: CCC. 2008, Bde. 19-9, 939-53.
25. Baumann F, Bloch W, Jäger E. Sport und körperliche Aktivität in der Onkologie.
Berlin Heidelberg : Springer Verlag, 2012.
26. Pham NM, Mizoue T, Tanaka K, et al. Physical activity and colorectal cancer risk:
an evaluation based on a systematic review of epidemiologic evidence among the Japanese population. Japanese journal of clinical oncology. 2012, Bde. 42-1, 2-13.
27. Wolin KY, Tuchman H. Physical activity and gastrointestinal cancer prevention.
recent results in cancer research. 2011, Bd. 186, 73-100.
28. Jaffer AA, Steven AC, Nora AJ, et al. Gastrointestinal Cancer. New York : Springer- Verlag, 2005.
29. Klinikum rechts der Isar, Technische Universität München. [Online] [Zitat vom: 22.
Juli 2014.] http://www.chir.med.tum.de/darmzentrum/boesartige-darmerkrankungen.
30. Henne-Bruns D, Kremer B, Dürig M. Kolon und Rektum. Duale Reihe Chirurgie, 3.
Auflage. Stuttgart : Georg-Thieme Verlag, 2007.
31. Darmkrebs.de. [Online] Felix-Burda-Stiftung, 28. April 2011. [Zitat vom: 23. Juli 2014.] www.darmkrebs.de.
32. Wolf M, Zehentmayr F, Belka C. Strahlentherapie des Rektumkarzinoms.
Radiologe. 2012, Bd. 52, 545-549.
33. Fong Y, Fortner J, Brennan MF, et al. Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases.
Annals of surgery. 1999, Bde. 230-3, 318-21.
34. Krajcovicova I, Bolješíková E, Sandorova M, et al. Preoperative radiotherapy of locally advanced rectal cancer: clinical outcome of short-course and long-course
treatment with or without concomitant chemotherapy. Klinická onkologie: casopis Ceské a Slovenské onkologické spolecnosti. 2012, Bde. 25-5, 364-9.
35. Bujko K, Nowacki MP, Nasierowska-Guttmejer A, et al. Sphincter preservation following preoperative radiotherapy for rectal cancer: report of a randomised trial comparing short-term radiotherapy vs. conventionally fractionated radiochemotherapy.
Radiotherapy and Oncology: Journal of the European Society for Radiotherapy and Oncology. 2004, Bde. 72-1, 15-24.
36. Germer CT. Staging beim Rektumkarzinom. Der Chirurg. 2012, Bde. 83-5, 421-422.
37. Van Gijn W, Marijnen CA, Nagtegaal ID, et al. Preoperative radiotherapy
combined with total mesorectal excision for resectable rectal cancer: 12-year follow-up of the multicentre, randomised controlled TME trial. The Lancet Oncology. 2011, Bde.
12-6, 575-82.
38. Folkesson J, Birgisson H, Pahlman L, et al. Swedish Rectal Cancer Trial: long lasting benefits from radiotherapy on survival and local recurrence rate. Journal of clinical oncology. 2005, Bde. 23-24, 5644-50.
39. Peeters KC, Marijnen CA, Nagtegaal ID, et al. The TME trial after a median follow-up of 6 years: increased local control but no survival benefit in irradiated patients with resectable rectal carcinoma. Annals of surgery. 2007, Bde. 246-5, 693-701.
40. Sebag-Montefiore D, Stephens RJ, Steele R, et al. Preoperative radiotherapy versus selective postoperative chemoradiotherapy in patients with rectal cancer (MRC CR07 and NCIC-CTG C016): a multicentre, randomised trial. Lancet. 2009, Bde. 373-96666, 811-20.
41. Gerard JP, Conroy T, Bonnetain F, et al. Preoperative radiotherapy with or without concurrent fluorouracil and leucovorin in T3-4 rectal cancers: results of FFCD 9203. journal of clinical oncology. 2006, Bde. 24-28, 4620-5.
42. Bosset JF, Collette L, Calais G. Chemotherapy with preoperative radiotherapy in rectal cancer. The New England journal of medicine. 2006, Bde. 355-11, 1114-23.
43. Sauer R, Becker H, Hohenberger W, et al. Preoperative versus postoperative chemoradiotherapy for rectal cancer. The New England journal of medicine. 2004, Bde.
351-17, 1731-40.
44. Roh MS, Colangelo LH, O’Connell MJ, et al. Preoperative multimodality therapy improves disease-free survival in patients with carcinoma of the rectum: NSABP R-03.
Journal of clinical oncology. 2009, Bde. 27-31, 5124-30.
45. Park JH, Yoon SM, Yu CS, et al. Randomized phase 3 trial comparing preoperative and postoperative chemoradiotherapy with capecitabine for locally advanced rectal cancer. Cancer. 2011, Bde. 117-16, 3703-12.
46. Maas M, Beets-Tan RG, Lambregts DM, et al. Wait-and-see policy for clinical complete responders after chemoradiation for rectal cancer. Journal of clinical oncology.
2011, Bde. 29-35, 4633-40.
47. Trakarnsanga A, Ithimakin S, Weiser MR. Treatment of locally advanced rectal cancer: controversies and questions. World journal of gastroenterology. 2012, Bde. 18-39, 5521-32.
48. Moertel CG, Fleming TR, Macdonald JS, et al. Intergroup study of fluorouracil plus levamisole as adjuvant therapy for stage II/Dukes' B2 colon cancer. Journal for clinical oncology. 1995, Bde. 13-12, 2936-43.
49. O'Connell MJ, Martenson JA, Wieand HS, et al. Improving adjuvant therapy for rectal cancer by combining protracted-infusion fluorouracil with radiation therapy after curative surgery. The New England journal of medicine. 1994, Bde. 331-8, 502-7.
50. Lee JH, Ahn JH, Bahng H, et al. Randomized trial of postoperative adjuvant
therapy in stage II and III rectal cancer to define the optimal sequence of chemotherapy and radiotherapy: a preliminary report. 2002, Bde. 20-7, 1751-8.
51. conference., NIH consensus. NIH consensus conference. Adjuvant therapy for patients with colon and rectal cancer. JAMA. 1990, Bde. 264-11, 1444-50.
52. Schmiegel W, Pox C, Arnold D, et al. Colorectal Carcinoma-The Management of Polyps, (Neo)Adjuvant Therapy, and the Treatment of Metastases. Deutsches Ärzteblatt International. 2009, Bde. 106-51-52, 843-8.
53. Liersch T, Langer C, Ghadimi BM, et al. Aktuelle Behandlungsstrategien beim Rektumkarzinom. Der Chirurg. 2005, Bd. 76, 309-334.
54. Hempen HG, Raab HR. Therapie des Lokalrezidivs nach Rektumkarzinom. Der Chirurg. 2009, Bd. 33, 14-18.
55. Parks AG, Porter NH,Hardcastle J. The syndrome of the descending perineum.
Proceedings of the Royal Society of Medicine. 1966, Bde. 59-6, 477-482.
56. Whistance RN, Conroy T, Chie W, et al. Clinical and psychometric validation of the EORTC QLQ-CR29 questionnaire module to assess health-related quality of life in patients with colorectal cancer. European journal of cancer. 2009, Bde. 45-17, 3017-26.
57. Schwarz R, Hinz A. Reference data for the quality of life questionnaire EORTC QLQ-C30 in the general German population. European Journal of Cancer. 2001, Bde.
37-11, 1345-1351.
58. Wiltink LM, Chen TY, Nout RA, et al. Health-related quality of life 14 years after preoperative. European Journal of Cancer. 2014, Bde. 50-14, 2390-2398.
59. How P, Stelzner S, Branagan G, et al. Comparative Quality of Life in Patients Following Abdominoperineal Excision and Low Anterior Resection for Low Rectal Cancer. Diseases of the colon and rectum,. 2012, Bde. 55-4, 400-406.
60. Guckenberger M, Saur G, Wehner D, et al. Long-term quality-of-life after
neoadjuvant short-course radiotherapy and long course radiochemotherapy for locally advanced rectal cancer. Radiotherapy and Oncology. 2013, Bde. 108-2, 326-30.
61. Welsch T, Mategakis V, Contin P, et al. Results of extralevator abdominoperineal resection for low rectal cancer including quality of life and long-term wound
complications. International journal of colorectal disease. 2013, Bde. 28-4, 503-510.
62. Arraras JI, Suárez J, Arias-de-la-Vega F, et al. Quality of life assessment by applying EORTC questionnaires to rectal cancer patients after surgery and neoadjuvant and adjuvant treatment. Revista española de enfermedades digestivas: organo oficial de la Sociedad Española de Patología Digestiva. 2013, Bde. 105-5, 255-261.
63. Engel J, Kerr J, Schlesinger-Raab A, et al. Quality of Life in Rectal Cancer
Patients-A Four-Year Prospective Study. Annals of Surgery. 2003, Bde. 238-2, 203-13.
64. Peng J, Shi D, Goodman KA, et al. Early results of quality of life for curatively treated rectal cancers in Chinese patients with EORTC QLQ-CR29. s.l. : Radiation oncology, 2011. DOI: 10.1186/1748-717X-6-93.
65. Michelson H, Bolund C, Nilsson B, et al. Health-related Quality of Life Measured by the EORTC QLQ-C30. Acta Oncologica. 2000, Bde. 39-4, 477-484.
66. Hjermstad MJ, Fayers PM, Bjordal K, et al. Health-Related Quality of Life in the General Norwegian Population Assessed by the European Organization for Research and Treatment of Cancer Core Quality-of-Life Questionnaire: The QLQ=C30 (+ 3).
Journal of Clinical Oncology. 1998, Bde. 16-3, 1188-1196.
67. Kripp M, Wieneke J, Kienle P, et al. Intensified neoadjuvant chemoradiotherapy in locally advanced rectal cancer - impact on long-term quality of life. European journal of surgical oncology. 2012, Bde. 38-6, 472-7.
68. Gujral S, Conroy T, Fleissner C, et al. Assessing quality of life in patients with colorectal cancer: An update of the EORTC quality of life questionnaire. European journal of cancer. 2007, Bde. 43-10, 1564-73.
69. Lange MM, van de Velde CJ. Urinary and sexual dysfunction after rectal cancer treatment. Nature reviews. Urologie. 2011, Bde. 8-1, 51-7.
70. Attaallah W, Ertekin C, Tinay I, et al. High Rate of Sexual Dysfunction Following Surgery for Rectal Cancer. Annals of coloproctology. 2014, Bde. 30-5, 210-5.
71. Milbury K, Cohen L, Jenkins R, et al. The association between psychosocial and medical factors with long-term sexual dysfunction after treatment for colorectal cancer.
Support Care Cancer. 2013, Bde. 21-3, 793-802.
72. Müller B, Nienaber CA, Reis O, et al. Sexuality and Affection among Elderly German Men and Women in Long-Term Relationships: Results of a Prospective
Population-Based Study. s.l. : PLoS One (Public Library Of Science), 2014. Bde. 9-11.
DOI: 10.1371/journal.pone.0111404.
73. Mercer CH, Tanton C, Prah P,et al. Changes in sexual attitudes and lifestyles in Britain through the life course and over time: findings from the National Surveys of Sexual Attitudes and Lifestyles (Natsal). Lancet. 2013, Bde. 382-9907, 1781-1794.
74. Theodoropoulos GE, Papanikolaou IG, Karantanos T, et al. Post-colectomy assessment of gastrointestinal function: a prospective study on colorectal cancer patients. Techniques in coloproctology. 2013, Bde. 17-5, 525-36.
75. Mastracci TM, Hendren S, O'Connor B, et al. The impact of surgery for colorectal cancer on quality of life and functional status in the elderly. Deseases of the colon and rectum. 2006, Bde. 49-12, 1878-84.
76. Halland M, Talley NJ. Fecal incontinence: mechanisms and management. Current opinion in gastroenterologie. 2012, Bde. 28-1, 57-62.
77. Hoppe De Mamani S, Schlag PM. Quality of life after rectal surgery. Der Chirurg.
2004, Bde. 75-1, 26-31.
78. Harisi R, Bodoky G, Borsodi M, et al. Rectal Cancer Therapy: Decision Making on Basis of Quality of Life? Zentralblatt für Chirurgie. 2004, Bde. 129-2, 139-148.
79. Sideris L, Zenasni F, Vernerey D, et al. Quality of life of patients operated on for low rectal cancer: impact of the type of surgery and patients' characteristics. deseases of the colon and rectum. 2005, Bde. 48-12, 2180-91.
80. Rauch P, Miny J, Conroy T, et al. Quality of Life Among Disease-Free Survivors of Rectal Cancer. Journal of Clinical Oncology. 2004, Bde. 22-2, 354-360.
81. Li XX, Song XM, Chen ZH, et al. Influence of clinical characteristics on health-related quality of life after mid-low rectal cancer surgery. Chinese journal of surgery.
2012, Bde. 50-12, 1057-62.
82. Probst M, Pages H, Riemann JF, et al. Fecal incontinence: part 4 of a series of articles on incontinence. Deutsches Ärzteblatt international. 2010, Bde. 107-34-35, 596-601.
83. Bryant CL, Lunniss PJ, Knowles CH. Anterior resection syndrome. The Lancet.
Oncology. 2012, Bde. 13-9, 403-8.
84. Guren MG, Eriksen MT, Wiig JN, et al. Quality of life and functional outcome following anterior or abdominoperineal resection for rectal cancer. European journal of surgical oncology. 2005, Bde. 31-7, 735-42.
85. Fischer A, Tarantino I, Warschkow R, et al. Is sphincter preservation reasonable in all patients? International journal of colorectal desease. 2010, Bde. 25-4, 425-32.
86. Pachler J, Wille-Jørgensen P. Quality of life after rectal resection for cancer, with or without permanent colostomy. s.l. : The Cochrane database of systematic reviews, 2012. DOI: 10.1002/14651858.CD004323.pub4.
87. Fischer F, Mirow L, Gondeck C, et al. Influence of adjuvant radio-chemotherapy for rectal cancer on quality of life. Zeitschrift für Gastroenterologie. Bde. 43-11, 1213-8.
88. Pollack J, Holm T, Cedermark B, et al. Long-term effect of preoperative radiation therapy on anorectal function. diseases of the colon and rectum. 2006, Bde. 49-3, 345-52.
89. Temple LK, Wong WD, Minsky B. The impact of radiation on functional outcomes in patients with rectal cancer and sphincter preservation. Seminars in radiation
oncology. 2003, Bde. 13-4, 469-77.
90. Marijnen CA, van de Velde CJ, Putter H, et al. Impact of short-term preoperative radiotherapy on health-related quality of life and sexual functioning in primary rectal cancer: report of a multicenter randomized trial. Journal of clinical oncology. 2005, Bde.
23-9, 1847–58.
91. Varpe P, Huhtinen H, Rantala A, et al. Quality of life after surgery for rectal cancer with special reference to pelvic floor dysfunction. Colorectal disease. 2011, Bde. 13-4, 399-405.
92. Bregendahl S, Emmertsen KJ, Lous J, et al. Bowel dysfunction after low anterior resection with and without neoadjuvant therapy for rectal cancer: a population-based cross-sectional study. Colorectal disease. 2013, Bde. 15-9, 1130-9.
93. Loos M, Quentmeier P, Schuster T, et al. Effect of Preoperative
Radio(chemo)therapy on Long-term Functional Outcome in Rectal Cancer Patients: A Systematic Review and Meta-analysis. Annals of Surgical Oncology. 2013, Bde. 20-6, 1816-28.
94. Pucciarelli S, Del Bianco P, Efficace F, et al. Health-related quality of life, faecal continence and bowel function in rectal cancer patients after chemoradiotherapy followed by radical surgery. Supportive care in cancer. 2010, Bde. 18-5, 601-8.
95. Joye I, Haustermans K. Early and late toxicity of radiotherapy for rectal cancer.
Recent results in cancer research. 2014, Bd. 203, 189-201.
96. Ranson R, Saffrey M. Neurogenic mechanisms in bladder and bowel ageing.
Biogerontology. 2015, Bde. 16-2, 265-84.
97. Contin P, Kulu Y, Bruckner T, et al. Comparative analysis of late functional outcome following preoperative radiation therapy or chemoradiotherapy and surgery or surgery alone in rectal cancer. International journal of colorectal disease. 2014, Bde. 29-2, 165-75.
98. Floodeen H, Lindgren R, Hallböök O, et al. Evaluation of long-term anorectal function after low anterior resection: a 5-year follow-up of a randomized multicenter trial.
Diseases of the colon and rectum. 2014, Bde. 57-10, 1162-8.
99. Siassi M, Hohenberger W, Lösel F, et al. Quality of life and patient's expectations after closure of a temporary stoma. International journal of colorectal disease. 2008, Bde. 23-12, 1207-12.
100. Neuman HB, Patil S, Fuzesi S, et al. Impact of a temporary stoma on the quality of life of rectal cancer patients undergoing treatment. Annals of surgical oncology. 2011, Bde. 18-5, 1397-403.